NEUREXIS THERAPEUTICS
Neurexis Therapeutics develops therapeutic peptide for post-insult neuroprotection.
NEUREXIS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Medical Neuroscience
Founded:
2020-01-01
Address:
Aurora, Colorado, United States
Country:
United States
Website Url:
http://www.neurexistherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
720-771-6670
Email Addresses:
[email protected]
Total Funding:
305 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Embrace Scar Therapy
Embrace Scar Therapy develops tissue repair devices for plastic surgery to minimize scar formation.
Current Employees Featured
Investors List
Colorado Office of Economic Development and International Trade
Colorado Office of Economic Development and International Trade investment in Grant - Neurexis Therapeutics
VIC Technology Venture Development
VIC Technology Venture Development investment in Seed Round - Neurexis Therapeutics
Official Site Inspections
http://www.neurexistherapeutics.com
- Host name: jib.gcmcomputers.com
- IP address: 148.59.95.12
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Neurexis Therapeutics"
Home - neurexistherapeutics.com
Neuroprotective Innovationfor Human Health Stroke and cardiac arrest affect millions of patients each year. Re-establishment of blood flow to the brain—although life-saving—does not address the substantial impact on …See details»
Neurexis Therapeutics - Crunchbase Company Profile & Funding
Organization. Neurexis Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email …See details»
Neurexis Therapeutics - LinkedIn
Neurexis Therapeutics | 214 followers on LinkedIn. Neuroprotective Innovation for Human Health | Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and ...See details»
Neurexis Therapeutics - Overview, News & Similar companies
Apr 19, 2023 Neurexis Therapeutics Awarded Colorado Advanced Industries Accelerator Grant Neurexis Therapeutics, Inc. announced today that it was approved for funding as part of the …See details»
Neurexis Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Neurexis Therapeutics, Inc. of Aurora, CO. Get the latest business insights from Dun & Bradstreet.See details»
Overview: www.neurexistherapeutics.com and degenerative …
Www.neurexistherapeutics.com Contact Dr. Michael Artinger, CEO +1-720-771-6670 michael.artinger@neurexistherapeuti cs.com Company Profile •Industry: Therapeutics • …See details»
Neurexis Therapeutics Company Profile | Management and
Www.neurexistherapeutics.com . Contact Information. Headquarters. 12635 E Montview Blvd Ste 100, Aurora, Colorado, 80045, United States (720) 771-6670. Neurexis Therapeutics Profile …See details»
About - neurexistherapeutics.com
People Michael Artinger, PhD - Chief Executive Officer and Board MemberThe focus of Dr. Artinger's career has been transforming innovation into commercial opportunity. He has worked closely with universities and inventors across the …See details»
Neurexis Therapeutics - PitchBook
Neurexis Therapeutics General Information Description. Developer of therapeutic peptides designed to significantly reduce brain damage from stroke. The company's platform provides …See details»
From the Corner Office: Neurexis Therapeutics - VIC Tech
Even with the scarcity of options, the neurology segment is one of the more challenging areas to develop a drug. Having said this, there has historically been a great deal of interest in the space as confirmed by past investment, …See details»
Neurexis Therapeutics - VIC Network
Neurexis Therapeutics was formed in early 2020 to develop a new medication for the prevention of brain damage following ischemic events such as cardiac arrest and stroke.See details»
Neurexis Therapeutics - Products, Competitors, Financials, …
Neurexis Therapeutics focuses on neuroprotective innovation in the biotechnology sector, aiming to improve global human health. Use the CB Insights Platform to explore Neurexis …See details»
News - neurexistherapeutics.com
News Neurexis Therapeutics Secures $3 Million NIH Grant to Advance Neuroprotective Treatment for Global Cerebral Ischemia September 18, 2024 - Neurexis Therapeutics, a …See details»
Neurexis Therapeutics Company Profile: Overview and Full News …
News Summary Neurexis Therapeutics, an Aurora, CO-based biopharmaceutical company focused on developing neuroprotective interventions, has been awarded a $3 million Phase II …See details»
Neurexis Therapeutics - VentureRadar
Develops tatCN19o, an optimized peptide for treating global cerebral ischemia, aiming to reduce brain damage and address a market gap. " Neurexis is developing tatCN19o, an optimized …See details»
Neurexis Therapeutics Works to Solve an Unmet Healthcare Need
Dec 21, 2020 The organization’s focus is to support the business development of early-stage… Learn More As the Colorado Prescription Drug Affordability Board (PDAB) begins affordability …See details»
Direct-to-Phase II SBIR Grant from NIH Awarded to Neurexis …
A promising approach for preventing cognitive and behavioral impairment following ischemia. Aurora, CO - Neurexis Therapeutics, Incorporated, announces it has been awarded $900,000 …See details»
From the Corner Office: Neurexis Therapeutics - LinkedIn
Feb 3, 2025 Meanwhile, the critical unmet need for neuroprotective options has become even more acute. By way of a brief, non-technical overview, our peptide (a short protein) called …See details»
Technology - neurexistherapeutics.com
Technology TatCN19o is a 30 amino acid peptide that includes two functional domains. The first domain facilitates the ability of the drug to cross cell membranes and the blood brain barrier. …See details»
Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to …
To learn more, visit neurexistherapeutics.com. About VIC Technology Venture Development, LLC VIC Technology Venture Development creates innovative new companies with world-changing …See details»